Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Recruiting
Observational Study
Pseudomonas Infections
Pseudomonas Septicemia
Pseudomonas; Pneumonia
Pseudomonal Bacteraemia
Pseudomonas Urinary Tract Infection
Pseudomonas Gastrointestinal Tract Infection
Sepsis
Sepsis, Severe
Critically Ill
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University of Ulm · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The present study focuses on patients with Pseudomonas aeruginosa (PSA) sepsis. The aim of the present study is to find out whether the M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotype predominates in blood monocytes in critically ill patients with PSA-sepsis, and whether the severity of sepsis and outcome is associated with distinct monocyte phenotype and function.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age \> 18 years
* critically ill patients with sepsis
* microbiologically proven infection with Pseudomonas aeruginosa
Exclusion Criteria:
* life expectancy \< 24 hours
* participation in other studies
Contacts